Rating History for Myriad Genetics (MYGN) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for MYGN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
10/20/2026 Dave Westenberg Upgrade Neutral
(Underweight)		 5.00
(N/A)		 4.21
(5.82)		 38.24% Details